Cargando…
Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis
PURPOSE: CR4056, (2-phenyl-6-(1H-imidazol-1yl) quinazoline), an imidazoline-2 (I2) receptor ligand, is a promising analgesic drug that has been reported to be effective in several animal models of pain. The aim of this study was to evaluate the effects of CR4056 in two well-established rat models of...
Autores principales: | Comi, Eleonora, Lanza, Marco, Ferrari, Flora, Mauri, Valeria, Caselli, Gianfranco, Rovati, Lucio Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422496/ https://www.ncbi.nlm.nih.gov/pubmed/28496359 http://dx.doi.org/10.2147/JPR.S132026 |
Ejemplares similares
-
Modulation of NMDA receptor activity by CR4056, an imidazoline-2 receptor ligand with analgesic properties
por: Puja, Giulia, et al.
Publicado: (2022) -
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain
por: Ferrari, Flora, et al.
Publicado: (2011) -
Modulation of imidazoline I(2) binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats
por: Lanza, Marco, et al.
Publicado: (2014) -
Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models
por: Sala, Emanuele, et al.
Publicado: (2020) -
I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice
por: Mota, Bibiana C., et al.
Publicado: (2022)